Adottati on 12/12/2012
Referenza:
INT/658-EESC-2012-2059Referral:
COM(2012) 369 final - 2012/0192 (COD)Rapporteur:
Sessjoni plenarja:
485 -
Dec 12, 2012 Dec 13, 2012
Due to the increased need for cost-efficient procedures and the pressure on public expenditure, the European market for pharmaceutical products is less dynamic than in the past. This high-technology sector is faced with the following challenges: austerity measures introduced by European governments, rapid growth in the market and research in emerging economies, and migration of economic, research and development activities outside of Europe.